Pulling SEC filings + quote and writing the call…

Franklin BSP Realty Trust, Inc.
Next earnings Jul 28, 2026 · consensus $0.26 EPS, $83.1M rev
Last earnings -2.4% on 2026-04-29
Cheap-to-book commercial mortgage REIT with a fat dividend, but rising office/multifamily NPLs and falling EPS cap the upside.
Diluted EPS (P/E 12.6) $0.64 · FY2025
Middling fundamentals offset by an attractive price (~51% below fair value) — worth a look on the value angle.
FBRT is a commercial mortgage REIT, so read the headline 'revenue' with care: the $29.6M XBRL contract-revenue line only captures servicing/fee income, not the net interest income that actually drives the business — which is why the reported 22.0x P/S and 277.6% net margin are artifacts, not signal. The economics that matter are net income of $82.3M, diluted EPS of $0.64 (P/E 12.6x), and $292M of operating cash flow (+410% YoY). The support case is real: the stock at $8.07 sits below book (equity of $1.44B on 81.0M shares, before preferred), management has an active $65M buyback explicitly struck 'below the most recently reported book value per share' and spent $14.4M repurchasing (+195% YoY), and the company paid $146M in dividends — a large, REIT-mandated distribution given the 90%-of-taxable-income rule.
But the trend is the other way. EPS fell 22% and net income fell 14.2% YoY, and ROE is a thin 5.7%. Credit is deteriorating in exactly the places that matter: non-performing loans jumped from 3 loans ($133.2M amortized cost) to 7 loans ($214.0M), including six multifamily and one office, and the held-for-investment book actually shrank from $4,908.7M to $4,383.1M while the weighted-average coupon slipped from 8.0% to 7.1% — less earning power on a smaller, riskier book. Retained earnings sit at -$411M and worsened 18.1%, reflecting distributions running well ahead of GAAP earnings. The 10-K's own performance graph shows FBRT returned $94.11 on a $100 October-2021 base through 2025 — a negative total return over 4+ years while the S&P 1500 nearly doubled.
Is FBRT a buy? The one-page verdict, explained →
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $4.76M | $9.65M | $17.0M | $22.8M | $29.6M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $25.7M | $14.4M | $145M | $95.9M | $82.3M |
| Diluted EPS | -$0.18 | -$0.38 | $1.42 | $0.82 | $0.64 |
| Net margin | 540.1% | 149.5% | 853.2% | 419.6% | 277.6% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results; directors elected, routine proposals ratified
Q1 2026 report; loan book shrinking, credit watch on rising nonperformers
Q1 2026 report; loan book shrinking, credit watch on rising nonperformers
Entered new material financing agreement, creating a direct debt obligation
Annual proxy: board slate, auditor, exec comp put to shareholder vote
FY25 10-K: NPLs up to 7 loans ($214M), loan book down 11%, EPS -22%
Q4/FY25 earnings furnished; EPS $0.64 down 22% YoY on lower net income
Officer/director change disclosed (Item 5.02 leadership transition)
Charter/bylaw amendment modifying security-holder rights plus holder vote
Sources: SEC EDGAR (CIK 0001562528, latest 10-Q filed 2026-04-29) · EODHD · Proprietary analysis · as of 7/3/2026, 3:56:36 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 2, 2026, 11:56 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 2 open-market buys · 0 sales
| 2026-06-15 | ORTALE BUFORD H Director | Buy | 25.9K @ $8.44 | $219K |
| 2026-06-15 | ORTALE BUFORD H Director | Buy | 3.70K @ $19.75 | $73.0K |
| 2026-06-08 | ORTALE BUFORD H Director | Award | 12.8K | |
| 2026-06-08 | Dumars Joe Director | Award | 12.8K | |
| 2026-06-08 | McDonough Peter J Director | Award | 12.8K | |
| 2026-06-08 | Tuppeny Elizabeth K. Director | Award | 12.8K | |
| 2026-06-08 | Augustine Patsy Joseph Director | Award | 12.8K | |
| 2026-03-03 | Buffone Brian President | Buy | 27.0K @ $9.41 | $254K |
| 2026-02-18 | ORTALE BUFORD H Director | Buy | 2.00K @ $8.77 | $17.5K |
| 2026-02-17 | ORTALE BUFORD H Director | Buy | 2.00K @ $8.88 | $17.8K |
| 2022-09-06 | ORTALE BUFORD H Director | Buy | 10.0K @ $20.00 | $200K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.